What Did This CEO Just Do with Personal Shares of Neogen Corp. (NASDAQ: NEOG)?By Carrie Williams
In addition to James Herbert, 4 other NEOG executives reported Sell trades in the last month. Following James Herbert’s last NEOG Sell transaction on November 16, 2016, the stock climbed by 2.4%.
Based on Neogen Corp.’s latest earnings report for the quarter ending August 31, the company posted quarterly revenue of $83.65 million and quarterly net profit of $9.88 million. In comparison, last year the company earned revenue of $74.86 million and had a net profit of $9.32 million. The company has a one year high of $63.40 and a one year low of $43.79. NEOG’s market cap is $2.38B and the company has a P/E ratio of 64.15.
The insider sentiment on Neogen Corp. has been negative according to 39 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
Neogen Corp. develops, manufactures and markets a diverse line of products dedicated to food and animal safety. It operates through two segments: Food Safety and Animal Safety. The Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and unintended substances in human food and animal feed. The Animal Safety segment engages in the development, manufacture and marketing of pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals, diagnostic products and genetic testing services for the worldwide animal safety market. The company was founded by Herbert D. Doan and James L. Herbert on June 30, 1981 and is headquartered in Lansing, MI.